期刊文献+

Gastrointestinal and hepatic complications of hematopoietic stem cell transplantation 被引量:3

Gastrointestinal and hepatic complications of hematopoietic stem cell transplantation
下载PDF
导出
摘要 Recognition and management of gastrointestinal and hepatic complications of hematopoietic stem cell transplantation has gained increasing importance as indications and techniques of transplantation have expanded in the last few years.The transplant recipient is at risk for several complications including conditioning chemotherapy related toxicities,infections,bleeding,sinusoidal obstruction syndrome,acute and chronic graftversus-host disease(GVHD) as well as other long-term problems.The severity and the incidence of many complications have improved in the past several years as the intensity of conditioning regimens has diminished and better supportive care and GVHD prevention strategies have been implemented.Transplant clinicians,however,continue to be challenged with problems arising from human leukocyte antigen-mismatched and unrelated donor transplants,expanding transplant indications and age-limit.This review describes the most commonly seen transplant related complications,focusing on their pathogenesis,differential diagnosis and management. Recognition and management of gastrointestinal and hepatic complications of hematopoietic stem cell transplantation has gained increasing importance as indications and techniques of transplantation have expanded in the last few years.The transplant recipient is at risk for several complications including conditioning chemotherapy related toxicities,infections,bleeding,sinusoidal obstruction syndrome,acute and chronic graftversus-host disease(GVHD) as well as other long-term problems.The severity and the incidence of many complications have improved in the past several years as the intensity of conditioning regimens has diminished and better supportive care and GVHD prevention strategies have been implemented.Transplant clinicians,however,continue to be challenged with problems arising from human leukocyte antigen-mismatched and unrelated donor transplants,expanding transplant indications and age-limit.This review describes the most commonly seen transplant related complications,focusing on their pathogenesis,differential diagnosis and management.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第16期1851-1860,共10页 世界胃肠病学杂志(英文版)
关键词 Stem cell transplantation Graft-versus-host disease Sinusoidal obstruction syndrome COMPLICATIONS 造血干细胞移植 并发症 胃肠道 肝脏 移植物抗宿主病 人类白细胞抗原 发病机制 鉴别诊断
  • 相关文献

参考文献69

  • 1Gratwohl A,Baldomero H,Aljurf M,Pasquini MC,Bouzas LF,Yoshimi A,Szer J,Lipton J,Schwendener A,Gratwohl M,Frauendorfer K,Niederwieser D,Horowitz M,Kodera Y. Hematopoietic stem cell transplantation: a global perspec- tive. JAMA 2010; 303: 1617x-1624.
  • 2Burt RK,Loh Y,Pearce W,Beohar N,Barr WG,Craig R, Wen Y,Rapp JA,Kessler J. Clinical applications of blood- derived and marrow-derived stem cells for nonmalignant diseases. JAMA 2008; 299: 925-936.
  • 3FACT-JACIE International Standards for Cellular Therapy Product Collection,Processing and Administration. 4th ed. Foundation for the Accreditation of Hematopoietic Cell Therapy. Omaha: Donor Evaluation and Management,2008: 98-105.
  • 4Confer DL,Miller JP,Chell JW. Bone marrow and periph- eral blood cell donors and donor registries. 4th ed. Thomas’ Hematopoeitic Cell Transplantation. Oxford: Blackwell Pub- lishing,2009: 544-554.
  • 5Arai S,Lee LA,Vogelsang GB. A systematic approach to hepatic complications in hematopoietic stem cell transplan- tation. J Hematother Stem Cell Res 2002; 11: 215-229.
  • 6Shuhart MC,Myerson D,Childs BH,Fingeroth JD,Perry JJ,Snyder DS,Spurgeon CL,Bevan CA,McDonald GB. Marrow transplantation from hepatitis C virus seropositive donors: transmission rate and clinical course. Blood 1994; 84: 3229-3235.
  • 7Peffault de Latour R,Lévy V,Asselah T,Marcellin P,Scieux C,Adès L,Traineau R,Devergie A,Ribaud P,Espérou H, Gluckman E,Valla D,Socié G. Long-term outcome of hepati- tis C infection after bone marrow transplantation. Blood 2004; 103: 1618-1624.
  • 8Hui CK,Lie A,Au WY,Ma SY,Leung YH,Zhang HY,Sun J,Cheung WW,Chim CS,Kwong YL,Liang R,Lau GK. Ef- fectiveness of prophylactic Anti-HBV therapy in allogeneic hematopoietic stem cell transplantation with HBsAg positive donors. Am J Transplant 2005; 5: 1437-1445.
  • 9Vance EA,Soiffer RJ,McDonald GB,Myerson D,Fingeroth J, Ritz J. Prevention of transmission of hepatitis C virus in bone marrow transplantation by treating the donor with alpha- interferon. Transplantation 1996; 62: 1358-1360.
  • 10Strasser SI,McDonald GB. Hepatitis viruses and hemato- poietic cell transplantation: A guide to patient and donor management. Blood 1999; 93: 1127-1136.

同被引文献4

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部